Baroness Rawlings

Conservative - Life peer

1 APPG membership (as of 15 Jun 2022)
Austria
3 Former APPG memberships
France, Hungary, Kazakhstan
Lord Speaker's Advisory Panel on Works of Art
25th Jan 2017 - 23rd Oct 2019
Works of Art Committee (Lords)
12th Jun 2014 - 31st Aug 2016
National Policy for the Built Environment Committee
18th Jun 2015 - 11th Feb 2016
Information Committee (Lords)
16th May 2013 - 14th May 2014
Lords Spokesperson (Department for Culture, Media and Sport)
11th May 2010 - 6th Sep 2012
Baroness in Waiting (HM Household) (Whip)
11th May 2010 - 25th Jun 2012
Administration and Works Committee (Lords)
26th Jun 2001 - 7th Nov 2002
Works of Art Committee (Lords)
23rd Nov 1999 - 7th Nov 2002
Administration and Works Committee (Lords)
17th Dec 1998 - 30th Nov 2000


Select Committee Meeting
Wednesday 29th June 2022
10:30
International Relations and Defence Committee - Oral evidence
Subject: Defence concepts and capabilities: from aspiration to reality
29 Jun 2022, 10:30 a.m.
At 10.30am: Oral evidence
Alessio Patalano - Professor at King's College London
Michael Stephens - Associate Fellow at RUSI
View calendar
Select Committee Meeting
Wednesday 6th July 2022
10:30
International Relations and Defence Committee - Oral evidence
Subject: Defence concepts and capabilities: from aspiration to reality
6 Jul 2022, 10:30 a.m.
At 10.30am: Oral evidence
Professor Jamie Shea - Professor at The University of Exeter
Professor Mark Webber - Professor at The University of Birmingham
At 11.30am: Oral evidence
Georgina Wright - Senior Fellow and Director, Europe Program at Institut Montaigne
Professor Christoph Meyer - Professor of European & International Politics at King's College London
View calendar
Division Votes
Tuesday 21st June 2022
Abortion (Northern Ireland) Regulations 2022
voted No - in line with the party majority
One of 88 Conservative No votes vs 13 Conservative Aye votes
Tally: Ayes - 28 Noes - 181
Speeches
Monday 28th March 2022
COP 26
My Lords, what assessment have the Government made of the effect of all the bombing in Ukraine on the COP …
Written Answers
Friday 22nd April 2022
Prescription Drugs
To ask Her Majesty's Government how many drugs which have received regulatory approval since January 2019 are only available through …
Early Day Motions
None available
Bills
None available
Tweets
None available
MP Financial Interests
None available

Division Voting information

During the current Parliamentary Session, Baroness Rawlings has voted in 222 divisions, and 1 time against the majority of their Party.

15 Jun 2020 - Abortion (Northern Ireland) (No. 2) Regulations 2020 - View Vote Context
Baroness Rawlings voted No - against a party majority and against the House
One of 24 Conservative No votes vs 127 Conservative Aye votes
Tally: Ayes - 355 Noes - 77
View All Baroness Rawlings Division Votes

Debates during the 2019 Parliament

Speeches made during Parliamentary debates are recorded in Hansard. For ease of browsing we have grouped debates into individual, departmental and legislative categories.

Sparring Partners
Baroness Barran (Conservative)
Parliamentary Under-Secretary (Department for Education)
(16 debate interactions)
Lord Bethell (Conservative)
(11 debate interactions)
Lord Callanan (Conservative)
Parliamentary Under-Secretary (Department for Business, Energy and Industrial Strategy)
(5 debate interactions)
View All Sparring Partners
Legislation Debates
Baroness Rawlings has not made any spoken contributions to legislative debate
View all Baroness Rawlings's debates

Commons initiatives

These initiatives were driven by Baroness Rawlings, and are more likely to reflect personal policy preferences.

MPs who are act as Ministers or Shadow Ministers are generally restricted from performing Commons initiatives other than Urgent Questions.


Baroness Rawlings has not been granted any Urgent Questions

Baroness Rawlings has not been granted any Adjournment Debates

Baroness Rawlings has not introduced any legislation before Parliament

Baroness Rawlings has not co-sponsored any Bills in the current parliamentary sitting


22 Written Questions in the current parliament

(View all written questions)
Written Questions can be tabled by MPs and Lords to request specific information information on the work, policy and activities of a Government Department
15th Jul 2021
To ask Her Majesty's Government what assessment they have made of the vehicle emissions produced by ministers travelling short distances in Range Rovers; and what plans they have to reduce such emissions by reducing the number of (1) short car journeys taken by ministers, and (2) Range Rovers used by ministers.

The Range Rover Cars on the Government Car Service (GCS) fleet are plug in hybrid electric vehicles.

(1) Short car journeys taken by ministers will be on electric power only with zero emissions.

(2) These same Range Rover Cars were classified as Ultra Low Emission Vehicles at time of procurement in 2018.

The GCS is continually reviewing fit for purpose vehicles for Ministerial use, and with support from the Department for Transport to meet emission targets for government fleets, the GCS will be replacing cars as they become due for renewal with a continuing focus on replacement vehicles being more environmentally friendly and where possible, using fully electric alternatives.

Baroness Vere of Norbiton
Parliamentary Under-Secretary (Department for Transport)
7th Apr 2022
To ask Her Majesty's Government what legislation requires Public Health England to provide antiviral treatments for COVID-19 to only those people with particular health conditions.

The pharmaceutical companies producing antivirals have not made these treatments commercially available to the private health care sector in the United Kingdom. These products have been procured by the Department and are only available through the National Health Service.

The Department has agreed contracts with MSD and Pfizer to ensure that the UK has sufficient antiviral medication to treat those who are likely to benefit. There is no legislation which sets out the patient cohorts to receive antiviral treatments for COVID-19. Clinically eligible cohorts have been determined by an independent expert group commissioned by the Department and included in a clinical policy agreed by the UK Chief Medical Officers.

Lord Kamall
Parliamentary Under-Secretary (Department of Health and Social Care)
7th Apr 2022
To ask Her Majesty's Government what contractual arrangements they have, if any, with pharmaceutical companies that prevent the sale of antiviral drugs for COVID-19 by private clinicians.

The pharmaceutical companies producing antivirals have not made these treatments commercially available to the private health care sector in the United Kingdom. These products have been procured by the Department and are only available through the National Health Service.

The Department has agreed contracts with MSD and Pfizer to ensure that the UK has sufficient antiviral medication to treat those who are likely to benefit. There is no legislation which sets out the patient cohorts to receive antiviral treatments for COVID-19. Clinically eligible cohorts have been determined by an independent expert group commissioned by the Department and included in a clinical policy agreed by the UK Chief Medical Officers.

Lord Kamall
Parliamentary Under-Secretary (Department of Health and Social Care)
7th Apr 2022
To ask Her Majesty's Government how many drugs which have received regulatory approval since January 2019 are only available through the NHS and cannot be prescribed by private physicians.

All authorised medicines and vaccines regulated by the Medicines and Healthcare products Regulatory Agency (MHRA) can be prescribed by a prescribing clinician as a private prescription. However, the decision to place a medicine or vaccine on the private market is a matter for the individual manufacturer. Information on drugs which have received the MHRA’s approval and solely available through the National Health Service is not held centrally.

Lord Kamall
Parliamentary Under-Secretary (Department of Health and Social Care)
29th Mar 2022
To ask Her Majesty's Government what assessment they have made of (1) the use of (a) molnupiravir, and (b) Paxlovid, as antiviral treatments for COVID-19 in other countries, and (2) the rules for administering such treatments, when considering how to administer and distribute those treatments in England.

Molnupiravir and nirmatrelvir + ritonavir (co-packaged as Paxlovid) are available for the treatment of COVID-19 in multiple countries. The Antivirals and Therapeutics Taskforce is engaging with international organisations and nations to share learning on the use and deployment of therapeutics and antivirals, including molnupiravir and Paxlovid.

Eligibility for oral antivirals has been determined by an independent expert group commissioned by the Department and included in a clinical policy agreed by the United Kingdom Chief Medical Officers. This policy is based on evidence that individuals with specific health conditions are more likely to progress to severe disease. In the community, eligible patients have access to oral antivirals through COVID Medicines Delivery Units in England, with equivalent arrangements in Scotland, Wales and Northern Ireland. In addition, Paxlovid is available to eligible patients who contract COVID-19 whilst in hospital. We are continuing to monitor international use and administration of these treatments to inform the clinical policy.

Lord Kamall
Parliamentary Under-Secretary (Department of Health and Social Care)
29th Mar 2022
To ask Her Majesty's Government, further to the Written Answer by Lord Kamall on 28 March (HL7225), why decisions on the deployment of antiviral treatments for COVID-19 for people beyond the highest risk groups are tied to the outcomes of the PANORAMIC study; and when they expect such decisions to be made.

We are ensuring that deployment of antiviral treatments is supported by comprehensive data on clinical and cost-effectiveness to ensure healthcare professionals and patients have full confidence in prescribing and receiving these treatments.

The PANORAMIC study was established following a recommendation from an expert clinical panel. The expert panel advised that additional information should be gathered on which patients would benefit most from antiviral treatments in the United Kingdom, given high rates of vaccination. Previous trials have predominantly used unvaccinated participants.

Results for the first antiviral treatment, molnupiravir, are likely to be available in summer 2022, when a decision on clinical access will be made by an expert panel. The second antiviral treatment, Paxlovid, is expected to enter the PANORAMIC study in April 2022.

Lord Kamall
Parliamentary Under-Secretary (Department of Health and Social Care)
24th Mar 2022
To ask Her Majesty's Government, further to the Written Answer by Lord Kamall on 24 March (HL7023), why they are retaining stocks of COVID-19 antiviral treatments.

The Government has secured 4.98 million patient courses of oral antiviral treatments. As a result, there are supplies of oral antivirals molnupiravir and nirmatrelvir+ritonavir held in the United Kingdom with regular deliveries to ensure sufficient treatment for patients. These are available to eligible patients in the community at highest risk of developing severe disease through COVID Medicines Delivery Units in England and equivalent arrangements in Scotland, Wales and Northern Ireland. In addition, nirmatrelvir + ritonavir is available to eligible patients who contract COVID-19 whilst in hospital.

We continue to monitor clinical trial results to understand which patient cohorts may benefit from oral antivirals, including the PANORAMIC national study. The results will inform our understanding of the performance of oral antivirals where the majority of the population is vaccinated and future decisions on patient access in the UK.

Lord Kamall
Parliamentary Under-Secretary (Department of Health and Social Care)
24th Mar 2022
To ask Her Majesty's Government how many COVID-19 patients are currently in hospital; whether those patients are being given antiviral treatments to aid their recovery; and if so, what is the average length of time it takes patients receiving such treatments to be cured.

As of 28 March 2022, the number of patients currently in hospital with COVID-19 is 17,685. A range of treatments are available to these patients, including antivirals. Eligible patients admitted to hospital for reasons not related to COVID-19 and subsequently test positive are able to access nirmatrelvir + ritonavir (Paxlovid), an oral antiviral treatment or remdesivir, an intravenous antiviral. For patients whose immune system means they are at higher risk of COVID-19, the antiviral treatments molnupiravir, nirmatrelvir + ritonavir and remdesivir are available in the community to reduce the risk of hospitalisation and death.

Approximately 120,000 treatments have been provided in England, of which 53,000 were antivirals administered to hospitalised patients. The data requested on the average time for patients receiving antivirals to be cured is not held centrally.

Lord Kamall
Parliamentary Under-Secretary (Department of Health and Social Care)
22nd Mar 2022
To ask Her Majesty's Government, further to the Written Answer by Lord Kamall on 21 March (HL6991), what body was responsible for the decision that antiviral treatments for COVID-19 can only be prescribed by a clinician within a COVID Medicine Delivery Unit and are not available for general practice prescribing and purchase directly from pharmacies; when this decision was taken, and why.

The decision was made by NHS England and NHS Improvement prior to December 2021, when the first COVID Medicine Delivery Units were launched. Any decisions on the longer-term deployment of COVID-19 treatments beyond the highest risk groups will be subject to the outcomes of the PANORAMIC study on the effectiveness of antivirals in the United Kingdom population.

Lord Kamall
Parliamentary Under-Secretary (Department of Health and Social Care)
16th Mar 2022
To ask Her Majesty's Government, further to the Written Answer by Lord Kamall on 15 March (HL6625), why antiviral treatments for COVID-19 can only be prescribed by a clinician within a COVID Medicine Delivery Unit and cannot be prescribed by private physicians.

The supply of COVID-19 oral antivirals is not yet commercially available, with the current United Kingdom stocks held by the Government. As there is no commercial supply of antivirals, private physicians are not able to prescribe antivirals to non-hospitalised patients.

Lord Kamall
Parliamentary Under-Secretary (Department of Health and Social Care)
15th Mar 2022
To ask Her Majesty's Government, further to the Written Answer by Lord Kamall on 15 March (HL6625), why antiviral treatments for COVID-19 can only be prescribed by a clinician within a COVID Medicine Delivery Unit and are not available for general practice prescribing and purchase directly from pharmacies.

Eligibility for treatments for non-hospitalised patients at highest risk following infection with COVID-19 is set out in a United Kingdom-wide clinical access policy agreed by the Government’s Chief Medical Officer. This policy provides four treatment options; an intravenous monoclonal antibody; an intravenous antiviral; and two oral antiviral options. The decision on the choice of treatment is led by the prescribing clinician who will consider the relative effectiveness of the medicines and the suitability for the individual patient. The intravenous treatments are typically provided in a hospital clinic setting and the oral treatments can usually be sent to the patient’s home or collected on the patient’s behalf from a named pharmacy.

Due to the current range of treatment options available, the targeted cohort of patients receiving treatment - many of whom will be managing health conditions with the support of hospital specialists - and the need to carefully manage available supply, approximately 100 COVID Medicine Delivery Units in England offer an integrated triage and treatment service. COVID-19 treatments within the UK are only available to eligible patients following a clinical assessment and are provided free of charge. These treatments cannot currently be purchased as an over-the-counter medicine. Any decisions on the longer-term deployment of COVID-19 treatments beyond the highest risk groups will be subject to the outcomes of the PANORAMIC study on the effectiveness of antivirals in the UK population.

Lord Kamall
Parliamentary Under-Secretary (Department of Health and Social Care)
3rd Mar 2022
To ask Her Majesty's Government, further to the Written Answer by Lord Kamall on 3 March (HL6393), why pharmacists are unable to (1) stock, and (2) sell, COVID-19 treatments including (a) molnupiravir, and (b) Paxlovid.

Community pharmacies dispense prescriptions issued by general practice. COVID-19 treatments, including the oral antiviral treatments molnupiravir and nirmatrelvir (Paxlovid), are not currently available for general practice prescribing. In England, these treatments are prescribed by a clinician within a COVID Medicine Delivery Unit. Where an oral antiviral treatment is prescribed, this can be collected from a named pharmacy usually in a hospital, or alternatively sent directly to the patient’s home.

Lord Kamall
Parliamentary Under-Secretary (Department of Health and Social Care)
23rd Feb 2022
To ask Her Majesty's Government, further to the Written Answer by Lord Kamall on 9 February (HL6141), whether pharmacists are able to (1) stock, and (2) sell, the antiviral medications (a) molnupiravir, and (b) Paxlovid.

Community pharmacies are not able to stock and sell COVID-19 treatments, including molnupiravir or PF-07321332+ritonavir, co-packaged as Paxlovid. Updates on accessing these medications will be provided in due course.

Lord Kamall
Parliamentary Under-Secretary (Department of Health and Social Care)
9th Feb 2022
To ask Her Majesty's Government, further to the remarks by Lord Kamall on 31 January (HL Deb cols 621–3), whether the antiviral pills molnupiravir and Paxlovid will be available for free on the National Health Service; and if not, how people will be able to get hold of them.

Molnupiravir and PF-07321332+ritonavir (co-packaged as Paxlovid) are currently available for eligible National Health Service patients through COVID Medicines Delivery Units (CMDUs). Eligible patients who receive a positive COVID-19 test result will be contacted by a clinician from a CMDU to discuss what treatments could be suitable for them.

For those patients not already exempt from prescription charges, we have announced that antiviral medicines prescribed via CMDUs will be supplied free of charge until 31 March 2022. This is supported by Regulation 13 of The National Health Service (Charges for Drugs and Appliances) Regulations 2015.

Lord Kamall
Parliamentary Under-Secretary (Department of Health and Social Care)
15th Jul 2021
To ask Her Majesty's Government what assessment they have made of (1) the quality of NHS COVID-19 PCR tests, (2) the reasons why airlines do not accept the results of NHS tests in order to travel, (3) the additional cost for travellers of paying for privately-provided tests, and (4) which private sector companies are benefitting from these business practices.

All polymerase chain reaction (PCR) tests are validated centrally and verified locally as a minimum prior to use. The results of the validation and verification are reviewed by independent subject matter experts in the field prior to laboratories testing individuals’ samples with the assays. PCR tests in all laboratories are subject to an enhanced variant of concern assurance program, facilitated by the Medicines and Healthcare products Regulatory Agency and NHS Test and Trace.

National Health Service tests cannot be used for travel in order to preserve existing testing capacity to protect public health. Since requirements were introduced for international travel testing, the costs of testing have fallen significantly. We are committed to working with the travel industry and private providers to reduce the cost of travel testing and we have made NHS Test and Trace tests available at the market mid-point.

A list of private providers used for testing purposes is attached, due to the size of the data. Some organisations which have self-declared that they meet the Government’s minimum standards for the type of testing service they offer have opted out from publication of their details of the Government’s centrally held list.

15th Jul 2021
To ask Her Majesty's Government what constitutes a COVID-19 (1) pilot scheme, (2) event research programme, (3) trial; and how many there have been of each of these in the last two years.

A pilot scheme tests a policy before it becomes operational to identify any delivery challenges and how these can be overcome ahead of wider deployment. A pilot is limited in its delivery by time period, volume, context or geography, or any combination of these. Within NHS Test and Trace there have been 158 pilot schemes.

The Events Research Programme (ERP) is a single cross-Government programme which ran a number of event pilots. It aims to examine the risk of transmission of COVID-19 from attendance at events to enable people to attend a range of events safely. The programme is exploring how a combination of testing and non-pharmaceutical interventions or actions that people can take to mitigate the spread of COVID-19, can inform decisions on safely lifting restrictions at events. The Department for Digital, Culture, Media and Sport is currently leading the ERP, which has conducted 42 pilot events within the programme.

Trials are put in place to identify solutions to a specific research question. They are run within formal research governance and are listed on an open science platform, available to the scientific community. The outcomes of trials are prepared for peer-reviewed publications. Information on the number of all such COVID-19 trials is not held centrally and can only be obtained at disproportionate cost.

Lord Kamall
Parliamentary Under-Secretary (Department of Health and Social Care)
15th Jul 2021
To ask Her Majesty's Government which civil servants are exempt from COVID-19 rules related to (1) travelling, and (2) mixing with groups of other people; and for what reasons they are exempt.

Crown servants and Government contractors, which includes civil servants must quarantine in a managed facility or in their own accommodation, depending on the ‘traffic light’ allocation of the country they departed from or transited through in the 10 days before arrival in the United Kingdom. This applies unless a relevant Government department has certified that they are not required to do so and the traveller is:

- a Crown servant or Government contractor travelling to the UK for essential Government work or returning from such work outside the UK; or

- returning from conducting essential state business outside of the UK; or

- returning to the UK where this is necessary to facilitate the functioning of a diplomatic mission or consular post of Her Majesty or of a military/other official posting on behalf of Her Majesty.

Civil servants meeting the first two of these eligibility criteria may also be exempt from the mandatory post-arrival testing requirements. Some civil servants who are conducting essential border work or essential defence activities are also exempt from the requirement to complete a Passenger Locator Form, as well as quarantine and travel testing requirements. While all social distancing restrictions are no longer mandated, the legal duty to self-isolate when notified by NHS Test and Trace remains in place applies to civil servants as to the wider public.

21st Apr 2021
To ask Her Majesty's Government in what circumstances patients are charged for the first two months of the prescription of new drugs; whether decisions on charging for new drugs are determined by (1) the NHS, or (2) the National Institute for Health and Care Excellence; whether the circumstances in which patients are charged for new drugs has changed in the last five years; and if so, (a) when, and (b) for what reasons.

Decisions on whether medicines are funded by the National Health Service are taken by clinical commissioning groups and there is a requirement to fund drugs recommended by the National Institute for Health and Care Excellence.

Where a drug is funded by the NHS there is no charge to the patient other than the prescription charge, from 1 April 2021 £9.35 per prescription item in England, that applies to medicines dispensed in the community. Around 89% of prescriptions are dispensed free of charge due to the extensive list of prescription charge exemptions. Since 1968, the only change to the list of medical exemption criteria was the introduction of the exemption for people undergoing cancer treatment in 2009, including the effects of cancer, or the effects of current or previous cancer treatment.

15th Jul 2021
To ask Her Majesty's Government in what circumstances people may be (1) prosecuted, and (2) fined, for breaking COVID-19 regulations.

Decisions on prosecution is a matter for the Crown Prosecution Service, based on evidence provided to them by law enforcement agencies, including the Police.

On the question of fines, data on the Fixed Penalty Notices (FPNs) issued under the COVID-19 regulations by police forces in England and Wales is published by the National Police Chiefs' Council (NPCC) on a monthly basis and can be found on the NPCC website.

The latest publication from 28th June 2021 can be found here and displays a list of the reasons for FPNs being processed:

https://cdn.prgloo.com/media/fefef3f0ea8241018b9bda2d33fa95be.pdf

Baroness Williams of Trafford
Minister of State (Home Office)
15th Jul 2021
To ask Her Majesty's Government whether clergy are no longer permitted to register marriages conducted in their churches; if so, why not; and what consultations they undertook with the Church of England prior to the introduction of the electronic register for marriages.

As a result of changes implemented under The Civil Partnerships, Marriages and Deaths (Registration etc.) Act 2019 all marriages in England and Wales are registered in an electronic register by a registrar for the district in which the marriage took place rather than in hard copy registers.

The Church of England were fully involved in the development of this policy, including direct engagement with Home Office Ministers. The Church of England has been supportive of the move to an electronic system of registration, including the move to include Mothers on Marriage Certificates as part of this.

Lord Greenhalgh
Minister of State (Home Office)
25th Jan 2021
To ask Her Majesty's Government which (1) County Courts, (2) Family Courts, (3) magistrates' courts, and (4) youth courts, have been closed since 2015; and for each such closure, how many (a) have been sold, and (b) stand empty.

The table below provides the status of all courts closed since 2015, shown by the jurisdictions as requested.

Name

Jurisdiction Closed

Date of Closure

Disposal Status

2015

Chesterfield County Court

County

31/10/2015

Disposed

Harrogate County Court

County/Family

30/09/2015

Disposed

Hereford County Court

County/Family

31/12/2015

Disposed

2016

Accrington County Court

County

31/03/2016

Disposed

Accrington Magistrates' Court

Magistrate

31/03/2016

Disposed

Aldershot & Farnham County Court

County/Family

31/01/2016

Disposed

Aylesbury Magistrates and County Court

Combined

30/09/2016

Building retained as Aylesbury Crown Court

Barnstaple Magistrates' and County Court (Crown part only)

Crown part only

30/06/2016

Building retained as Barnstable Magistrates, County and Family Court

Brecon Law Courts

Combined

30/09/2016

Disposed

Bridgend Law Courts

Combined

29/07/2016

Disposed

Burton upon Trent Magistrates' Court

Magistrate

30/09/2016

Disposed

Bury St Edmunds Crown & Magistrates' Court

Combined

07/10/2016

Disposed

Buxton Magistrates' & County Court

Combined

30/06/2016

Disposed

Caerphilly Magistrates' Court

Magistrate

30/05/2016

Disposed

Carmarthen Law Courts (The Guildhall)

Combined

27/05/2016

Disposed

Consett Magistrates' Court

Magistrate

29/07/2016

Disposed

Corby Magistrates' Court

Magistrate

01/07/2016

Disposed

Dartford Magistrates' Court

Magistrate/Family

03/05/2016

Disposed

Dolgellau Crown & Magistrates' Court

Combined

25/08/2016

Disposed

Doncaster County Court

County/Family

03/05/2016

Disposed

Dorchester Crown Court (Weymouth & Dorchester Combined)

Combined

30/09/2016

Disposed

Fareham Magistrates' Court

Magistrate

30/09/2016

Disposed

Feltham Magistrates' Court

Magistrate

30/09/2016

Disposed

Gloucester Magistrates' Court

Magistrate

09/12/2016

Disposed

Grantham Magistrates' Court

Magistrate

30/06/2016

Disposed

Greenwich Magistrates' Court

Magistrate

27/05/2016

Disposed

Halifax County Court

County

02/12/2016

Disposed

Halifax Magistrates' Court (Calderdale)

Magistrate/Family

30/09/2016

Disposed

Hammersmith Magistrates' and County Court (County Court Only)

County part only

24/06/2016

Disposed

Hinckley Magistrates' Court

Magistrate

31/07/2016

Disposed

Kettering Magistrates' Court

Magistrate

30/06/2016

Disposed

King's Lynn County Court

County

30/09/2016

Disposed

Lowestoft Magistrates' Court

Magistrate

30/09/2016

Disposed

Macclesfield County Court

County

29/07/2016

Disposed

Macclesfield Magistrates' Court

Magistrate

30/09/2016

Disposed

Morpeth & Berwick County Court

County

30/05/2016

Disposed

Neath and Port Talbot Civil and Family Court

Combined

29/07/2016

Disposed

Oldham Magistrates' Court

Magistrate

30/09/2016

Disposed

Ormskirk Magistrates' Court

Magistrate

28/06/2016

Disposed

Pontypridd Magistrates' Court

Magistrate

29/07/2016

Disposed

Prestatyn Magistrates' Court

Magistrate

15/08/2016

Building retained as Prestatyn Justice Centre

Rhyl County Court

County

04/11/2016

Disposed

Richmond Upon Thames Magistrates’ Court

Magistrate

18/03/2016

Disposed

Rotherham Magistrates' & County Court

Combined

30/09/2016

Disposed

Sandwell Magistrates' Court

Magistrate

30/09/2016

Disposed

Shrewsbury Magistrates' Court

Magistrate

31/03/2016

Building retained as Shrewsbury Crown Court

Skegness Magistrates' Court

Magistrate

30/09/2016

Disposed

Solihull Magistrates' Court

Magistrate

31/03/2016

Disposed

St Helens Magistrates' Court

Magistrate

24/06/2016

Building retained as St Helens County and Family Court

Stroud Magistrates' Court

Magistrate

30/09/2016

Disposed

Swansea Crown Court (Guildhall)

Crown

27/05/2016

Disposed

Tameside Magistrates' & County Court (County Part Only)

County part only

30/06/2016

Building retained as Tameside Magistrates’ Court

Trafford Magistrates' Court & Altrincham County Court

Combined

30/06/2016

Disposed

Tunbridge Wells County Court

County/Family

09/12/2016

Disposed

Wakefield & Pontefract Magistrates' Court

Magistrate

26/09/2016

Disposed

Waltham Forest Magistrates’ Court

Magistrate

30/03/2016

Disposed

Warrington Combined Court (County Part Only)

County part only

30/09/2016

Building retained as Warrington Crown Court

West Berkshire Magistrates' Court (Newbury)

Magistrate

24/06/2016

Disposed

Weymouth & Dorchester Combined Court (Westwey House)

Combined

25/04/2016

Disposed

Worksop Magistrates' Court

Magistrate

31/03/2016

Disposed

Yate Magistrates' Court (North Avon)

Magistrate

30/09/2016

Disposed

Yeovil County Court

County

25/11/2016

Disposed

2017

Bicester Magistrates' Court

Magistrate

19/05/2017

Disposed

Bolton Combined Court Centre (County Part Only)

County part only

09/06/2017

Building retained as Bolton Law Courts

Bolton Magistrates' Court

Magistrate

30/11/2017

Disposed

Bournemouth Magistrates' Court

Magistrate

27/01/2017

Disposed

Bow County Court

County/Family

30/06/2017

Disposed

Bury Magistrates' & County Court

Combined

09/06/2017

Disposed

Caernarfon Civil and Family Court

County/Family

18/08/2017

Disposed

Chichester Magistrates' Court

Magistrate

02/06/2017

Awaiting disposal

Dover Magistrates' Court

Magistrate

26/05/2017

Disposed

Eastbourne Magistrates' & County Court

Magistrates/Family

29/09/2017

Disposed

Hammersmith Magistrates’ Court

Magistrate

31/12/2017

Disposed

Hartlepool Magistrates' & County Court

Combined/Family

30/01/2017

Awaiting disposal

Holyhead Magistrates' Court

Magistrate

28/04/2017

Disposed

Kendal Magistrates' & County Court

Combined

30/06/2017

Disposed

Kettering County Court

County

07/07/2017

Disposed

Lambeth County Court

County/Family

22/12/2017

Disposed

Lancaster County Court

County/Family

01/12/2017

Disposed

Llangefni Civil and Family Court

County/Family

18/08/2017

Disposed

Oldham County Court

County/Family

14/07/2017

Disposed

Redhill Magistrates' & Reigate County Court

Combined

31/03/2017

Disposed

Runcorn (Halton) Magistrates' Court

Magistrate

13/01/2017

Disposed

Scunthorpe Magistrates' & County Court

Combined

13/01/2017

Awaiting disposal

St Albans Crown & County Court (County Part Only)

County part only

28/07/2017

Building retained as St Albans Crown Court

Stafford Magistrates' Court

Magistrate/Family

28/04/2017

Disposed

Telford County Court

County/Family

29/09/2017

Currently being used as a temporary Nightingale Court

Torquay Magistrates' Court

Magistrate

01/09/2017

Awaiting disposal

Tottenham Magistrates' Court

Magistrate

10/02/2017

Disposed

Warrington Magistrates' Court

Magistrate

13/01/2017

Disposed

Watford Magistrates' Court

Magistrate

28/07/2017

Disposed

Woolwich County Court

County/Family

30/06/2017

Disposed

2018

Birmingham Magistrates' Youth Court

Magistrate/Youth

31/01/2018

Disposed

Chichester Combined Court

Combined

28/12/2018

Awaiting disposal

Chippenham Magistrates' & Civil Court

Combined/Family

27/07/2018

Disposed

Maidenhead Magistrates’ Court

Magistrate

31/12/2018

Awaiting disposal

Sunderland County Court

County/Family

07/09/2018

Awaiting disposal

2019

Banbury Magistrates’ and County Court

Combined

31/03/2019

Disposed

Blackfriars Crown Court

Crown

20/12/2019

Disposed

Camberwell Green Magistrates' Court

Magistrate

31/01/2020

Disposed

Chorley Magistrates’ Court

Magistrate

29/03/2019

Awaiting disposal

Colchester County Court

County/Family

30/04/2019

Disposed

Fleetwood Magistrates’ Court (currently sitting as a Family Hearing Centre)

Magistrate/Family

26/04/2019

Currently being used as a temporary Nightingale Court

Harlow Magistrates' Court

Magistrate

30/04/2019

Awaiting disposal

Northallerton Magistrates' Court

Magistrate/Family

30/04/2019

Disposed

Shrewsbury Crown Court

Crown

08/03/2019

Disposed

Southend County Court

County/Family

06/09/2019

Disposed

Disposed = The property has either been sold, or our tenancy has ended. The property is no longer part of the HMCTS estate.

Awaiting disposal = The property is closed and disposal is pending.

Ensuring that we can operate safely during the Covid-19 pandemic is our top priority. We have put in place measures in our court rooms so that they can hold Covid-19 secure trials, moved to virtual hearings where possible and opened additional court rooms in Nightingale courts as part of a package to increase available capacity.

We have now opened Nightingale courts at 21 locations, including the use of former court buildings, bringing the total number of temporary court rooms set up nationwide to 40. These additional temporary courtrooms have allowed us to increase capacity, particularly for jury trials, in locations where there is an operational requirement and hold additional hearings within a safe environment.